How immersive technology could drive the future of healthcare

How immersive technology could drive the future of healthcare

Jeffrey Tan
11/01/19, 11:39 am

SINGAPORE (Jan 11): Immersive technology is ­increasingly being deployed in various fields other than electronic games and entertainment. 

Take medicine for example, where Singapore start-up BetaSight is using virtual reality (VR) headsets to make the diagnosis of glaucoma easier. 

Glaucoma is an eye condition in which the optic nerve is damaged as a result of ­abnormally high pressure in the eye. If the damage continues, it can cause permanent vision loss. 

BetaSight’s solution tracks a patient’s eye movements in response to pop-up virtual objects generated by the VR headset.

According to BetaSight’s founders, the current process of diagnosis can be taxing and lead to skewed results. One of the start-up’s investors even had to take the test twice, and was charged double the price.

With BetaSight’s VR headsets, patients do not have to sit still or press any buttons – unlike the traditional procedure which uses a visual field analyser.

Instead, they only have to put on the VR headset and track the virtual objects with their eyes, which is more intuitive than pressing a button. A person who has glaucoma will have a diminished field of vision and not be able to spot all of the virtual objects.

The VR headset is portable and considerably less bulky than the visual field analyser equipment in use today.

In our latest issue of The Edge Singapore (Issue 864, week of Jan 14), Betasight’s founders Martin Sawtell and Corey Manders tell us how they first came up with the idea of using VR technology to diagnose glaucoma, as well as discuss the enormous potential of VR and AR technologies.

Login to read the full story, BetaSight develops better vision test using virtual reality headsets, or click here to subscribe.

Hyflux gets non-binding letter of intent from China suitor

SINGAPORE (June 15): Hyflux has received another non-binding letter of intent (LOI) for a potential investment in the group by an investor based in China. In a Friday night filing, Hyflux says the investor is a subsidiary of a state-owned enterprise in the industrial field which works on a global scale to provide comprehensive power services. “Other fields of expertise of the investor’s holding company include wind and solar energy solutions, nuclear industry, medical technology and agriculture,” says Hyflux. See: Rags-to-riches tale goes sour for Hyflux founder Olivia Lum Se....

Hong Kong suspends China extradition bill

(June 15): Hong Kong’s leader suspended efforts to pass a bill allowing extraditions to China, in a dramatic reversal that she said was necessary to restore order in the Asian financial hub and avoid further violence and mass protests. Carrie Lam, Hong Kong’s chief executive, announced the legislative “pause” at a news conference Saturday, even as activists asked hundreds of thousands of residents who marched in protest last weekend to return to the streets and demand her resignation. Lam acknowledged that debate had shattered a period of relative calm in the former British colony, ....

Chip Eng Seng in joint $47.5 mil investment of China distressed property company

SINGAPORE (June 15): Chip Eng Seng and controlling shareholder Haiyi Investment are jointly investing RMB240 million ($47.5 million) in a distressed property company based in Taicang city in Jiangsu province, China. Chip Eng Seng says the investment will enable the project company to discharge its outstanding liabilities such that its assets will be unsealed and restart a project involving the development and construction of a residential development on a land area of 38,000 sqm, with a gross floor area of 111,111 sqm. The project company, effective controlled by local shareholder Ren We....